Niksan Pharmaceutical is one of the most leading manufacturer,supplier, distributer and exporter of ProgesteroneAPI and finished formulation as all dosage form like solution and intramuscularinjection. Our product Progesterone is widely used and appreciated by our groupcompanies and also our customers and users all around the nations. We offer theProgesterone in very affordable price.
Niksan Pharmaceutical is the supplier, manufacturer, exporter and traderin the domestic level as well as the international market.
Niksan Pharmaceutical provides API and finished formulations of Progesterone in all over Indian stateslike Nagaland, Jammu & Kashmir, Pondicherry, Kerala, Tamil Nadu,Uttarakhand, Telangana, Himachal Pradesh, Goa, Karnataka, Manipur, Meghalaya,Punjab, Haryana, Chhattisgarh, Maharashtra, Gujarat, Chandigarh, Delhi, Odisha,Assam, West Bengal, Rajasthan, Madhya Pradesh, Bihar etc.
Niksan pharmaceutical is also large exporters of the API andfinished pharmaceutical products of Progesteronein many countries for years. The countries where we exporting are UnitedStates, Nigeria, Australia, Italy, Ghana, New Zealand, Ireland, Canada, SouthAfrica, Lebanon, Kenya, Singapore, United Arab Emirates, Sri Lanka, Algeria,Pakistan, France, Malaysia, Hong Kong, Bangladesh, Switzerland, Egypt, Morocco,Belgium, Vietnam, Greece, South Korea, Hungary, Thailand, Sweden, Iran, Romania and many other countries.
Progesterone is used to treatment of gynaecological disorders and also used inwomen to support pregnancy and fertility.
SYNONYMS: (S)-Progesterone, 17alpha-Progesterone, Agolutin, Akrolutin,Corpus Luteum Hormone, Gelbkrperhormon, Luteohormone, Lutogynon, Progesteron,Progesterona, Progestrone, Progesterone, Progesteronum
IUPAC NAME: (1S,3aS,3bS,9aR,9bS,11aS)-1-acetyl-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one
CAS NO: 57-83-0
FORMULA: C21H30O2
MOLECULAR MASS: 314.46 g/mol
STORAGE OF Progesterone: Store in cool and dry place. Do not put in bathroomor kitchen. Donot use Progesterone after the expiration.
APPLICATIONS OF Progesterone:Progesteroneis used to treatment of gynaecological disorders and also used in women tosupport pregnancy and fertility. Progesteroneis used in combination with the hormone estrogen to "oppose estrogen"as part of hormone replacement therapy.
HOW TO USE: Progesteronesold in market as a capsule form so you can take this medicine by mouth. It is generallytaken once a day in the evening or at bedtime.
HOW ProgesteroneWORKS:Progesterone prepares the endometrial for thepotential of pregnancy after ovulation.
CONTRAINDICATIONS:If you are a patient of breast cancer or diabeteskindly avoid this drug. Kindly avoid this medication if you have a high bloodpressure problem and depression. Do not take this medication if you a patientof liver disease and liver tumour. If you have a coronary artery disease andclot in the lung kindly avoid Progesterone.
PHARMACOKINETICS OF Progesterone:After oraladministration Progesterone metabolized mainly in liver. Half-life ofProgesterone is approximately 25 to 50 hours. Peak plasma concentration ofProgesterone is 6.5 to 10.2 mg/ml. Progesteron is mainly excreted by kidney andurine.
SIDE EFFECTS OF Progesterone: Most common side effect of Progesteronis Headache, Vision changes, Vertigo, Low blood pressure, Changes in heartrate, Coughing, Depression, Fatigue, Menstrual changes, Confusion andDifficulty in breathing. Other side effects of Progesteron is allergic reactionlike Skin rash or itchy skin, Tightness in the chest, Tingling in the mouth orthroat, Trouble breathing, Swelling in the hands or face.
PRECAUTION: Consult with your doctor if you have pain in thechest, groin or legs. Stop using Progesterone if you have sudden difficultywith breathing or unexplained shortness of breath.
CDSCO APPROVAL: Norgestrel + hydroxy progesterone +norethisterone + acetoxy progesterone January-1969
Isopregnenone,dydrogestrone tablet is approved by CDSCO in India in Auust-1962
Medroxyprogesterone acetate tablet is approved by CDSCO in India in June-1986
Progesteronemicronized soft gelatine capsule is approved by CDSCO in India in 21.06.1995
Medroxyprogesteroneacetate suspension for injection, Single dose container with 104mgMedroxyprogesterone acetate in 0.65 ml suspension for injection (SAYNA PRESS) (Additionalroute/ strength/indication) is approved by CDSCO in India in 18.12.2014
Lynestrenoltablet is approved by CDSCO in India in January-1964
Progesteronepessary tablet is approved by CDSCO in India in 25.10.2001
FORMULATIONS AVAILABLE IN MARKET:
Progesterone25 MG /ML Injections
Progesterone50 MG /ML Injections
Progesterone300 MG Tablets
Progesterone200 MG Tablets
Progesterone100 MG Tablets
Progesterone400 MG Tablets
Progesterone100 MG /ML Injections
Progesterone200 MG /ML Injections
Progesterone22.35 MG /ML Injections
Progesterone12.5 %W/V /ML Injections
L-methylfolate500 MCG + Progesterone 200 MG Tablets
Note: Product protected by valid patents are not offered for sale incountries where such patents are still valid and its liability is at BuyersRisk.
REFERENCES:
www.webmd.com
https://pubchem.ncbi.nlm.nih.gov
https://go.drugbank.com
https://cdscoonline.gov.in
https://www.wikipedia.org/
https://www.drugs.com
https://www.zaubacorp.com
https://www.practo.com/consult
Price:
![]() |
NIKSAN PHARMACEUTICAL
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |